Headlands Technologies LLC Has $1.32 Million Position in Sabra Healthcare REIT, Inc. $SBRA

Headlands Technologies LLC increased its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 333.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 67,486 shares of the real estate investment trust’s stock after buying an additional 51,905 shares during the period. Headlands Technologies LLC’s holdings in Sabra Healthcare REIT were worth $1,317,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in SBRA. Rothschild Investment LLC increased its position in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares during the period. Smartleaf Asset Management LLC lifted its holdings in shares of Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 714 shares during the period. Strengthening Families & Communities LLC acquired a new position in shares of Sabra Healthcare REIT during the fourth quarter worth $29,000. Versant Capital Management Inc grew its stake in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the third quarter worth $30,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on SBRA shares. Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Citizens Jmp upped their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. UBS Group set a $25.00 price target on Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Truist Financial raised their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Finally, Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, August 4th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $22.17.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.39 on Tuesday. The company has a market capitalization of $5.21 billion, a PE ratio of 78.43, a P/E/G ratio of 1.57 and a beta of 0.64. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT, Inc. has a twelve month low of $17.17 and a twelve month high of $22.77. The firm has a fifty day simple moving average of $20.47 and a 200 day simple moving average of $20.17.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $230.11 million for the quarter, compared to the consensus estimate of $219.39 million. During the same period last year, the company posted $0.38 EPS. The business’s revenue was up 24.7% compared to the same quarter last year. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is presently 461.54%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.